Sun Pharma Advanced Research Company Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

32.45

32.45

27.19

26.21

26.21

Share application money

-

-

234.26

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

92.40

480.32

-230.22

-194.46

-44.84

Loan funds

Secured loans

47.00

0.05

75.00

196.72

67.80

Unsecured loans

-

-

-

-

-

Total

171.86

512.83

106.23

28.46

49.16

Uses of funds

Fixed assets

Gross block

147.04

145.41

132.55

122.12

135.33

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

44.40

39.66

40.68

31.56

31.46

Net block

102.65

105.75

91.87

90.56

103.86

Capital work-in-progress

43.79

27.00

26.37

5.23

32.07

Investments

2.22

290.90

11.66

6.43

8.49

Net current assets

Current assets, loans & advances

337.67

406.48

150.18

127.47

128.14

Less : current liabilities & provisions

314.48

317.30

173.86

201.23

223.40

Total net current assets

23.20

89.18

-23.67

-73.75

-95.26

Miscellaneous expenses not written

-

-

-

-

-

Total

171.86

512.83

106.23

28.46

49.16

Notes:

Book value of unquoted investments

-

290.90

11.66

6.43

8.49

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

422.56

84.97

167.13

95.28

95.62

Number of equity sharesoutstanding (Lacs)

3245.22

3245.22

2718.79

2620.48

2620.48